140 related articles for article (PubMed ID: 27438535)
1. Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse Liver.
Sachar M; Li F; Liu K; Wang P; Lu J; Ma X
Chem Res Toxicol; 2016 Aug; 29(8):1293-7. PubMed ID: 27438535
[TBL] [Abstract][Full Text] [Related]
2. Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin.
He L; Guo Y; Deng Y; Li C; Zuo C; Peng W
Xenobiotica; 2017 Feb; 47(2):154-163. PubMed ID: 28118809
[TBL] [Abstract][Full Text] [Related]
3. The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis.
Brewer CT; Yang L; Edwards A; Lu Y; Low J; Wu J; Lee RE; Chen T
Toxicol Sci; 2019 Mar; 168(1):209-224. PubMed ID: 30517741
[TBL] [Abstract][Full Text] [Related]
4. Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria.
Parker CJ; Desnick RJ; Bissel MD; Bloomer JR; Singal A; Gouya L; Puy H; Anderson KE; Balwani M; Phillips JD
Mol Genet Metab; 2019 Nov; 128(3):309-313. PubMed ID: 31395332
[TBL] [Abstract][Full Text] [Related]
5. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.
Li F; Lu J; Cheng J; Wang L; Matsubara T; Csanaky IL; Klaassen CD; Gonzalez FJ; Ma X
Nat Med; 2013 Apr; 19(4):418-20. PubMed ID: 23475203
[TBL] [Abstract][Full Text] [Related]
6. Protoporphyrin IX: the Good, the Bad, and the Ugly.
Sachar M; Anderson KE; Ma X
J Pharmacol Exp Ther; 2016 Feb; 356(2):267-75. PubMed ID: 26588930
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid inhibits human erythroid 5-aminolevulinate synthase: Molecular mechanism and tolerance study with four X-linked protoporphyria patients.
Fratz-Berilla EJ; Breydo L; Gouya L; Puy H; Uversky VN; Ferreira GC
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):428-439. PubMed ID: 27838491
[TBL] [Abstract][Full Text] [Related]
8. Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.
Kemmner W; Wan K; Rüttinger S; Ebert B; Macdonald R; Klamm U; Moesta KT
FASEB J; 2008 Feb; 22(2):500-9. PubMed ID: 17875605
[TBL] [Abstract][Full Text] [Related]
9. Liver metabolomics in a mouse model of erythropoietic protoporphyria.
Wang P; Sachar M; Guo GL; Shehu AI; Lu J; Zhong XB; Ma X
Biochem Pharmacol; 2018 Aug; 154():474-481. PubMed ID: 29906468
[TBL] [Abstract][Full Text] [Related]
10. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
[TBL] [Abstract][Full Text] [Related]
11. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
12. A High Dose of Isoniazid Disturbs Endobiotic Homeostasis in Mouse Liver.
Li F; Wang P; Liu K; Tarrago MG; Lu J; Chini EN; Ma X
Drug Metab Dispos; 2016 Nov; 44(11):1742-1751. PubMed ID: 27531952
[TBL] [Abstract][Full Text] [Related]
13.
Xu L; Qi Q; Zhu J; Ma X
Chem Res Toxicol; 2022 Dec; 35(12):2186-2193. PubMed ID: 36459538
[No Abstract] [Full Text] [Related]
14. Relationship between N-acetyltransferase (NAT) activity and liver protoporphyrin level in experimental porphyria.
Watanabe M; Irifune H; Ohgami T; Nonaka S
J Dermatol; 1996 Apr; 23(4):238-42. PubMed ID: 8935337
[TBL] [Abstract][Full Text] [Related]
15. Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits.
Sarich TC; Youssefi M; Zhou T; Adams SP; Wall RA; Wright JM
Arch Toxicol; 1996; 70(12):835-40. PubMed ID: 8911642
[TBL] [Abstract][Full Text] [Related]
16. Melatonin and environmental lighting regulate ALA-S gene expression and So porphyrin biosynthesis in the rat harderian gland.
Lyoumi S; Martin-Schmitt C; Touitou Y; Puy H; Djeridane Y
Chronobiol Int; 2008 Nov; 25(6):851-67. PubMed ID: 19005892
[TBL] [Abstract][Full Text] [Related]
17. The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury.
Zhang M; Zhu J; Wang N; Liu W; Lu L; Pan H; He X; Yi H; Tang S
J Clin Pharm Ther; 2022 Aug; 47(8):1276-1283. PubMed ID: 35470464
[TBL] [Abstract][Full Text] [Related]
18. Role of CYP3A in isoniazid metabolism in vivo.
Liu K; Li F; Lu J; Gao Z; Klaassen CD; Ma X
Drug Metab Pharmacokinet; 2014; 29(2):219-22. PubMed ID: 24172716
[TBL] [Abstract][Full Text] [Related]
19. Liaison between heme metabolism and bioenergetics pathways-a multimodal elucidation for early diagnosis of oral cancer.
Sarkar R; Chatterjee K; Ojha D; Chakraborty B; Sengupta S; Chattopadhyay D; RoyChaudhuri C; Barui A
Photodiagnosis Photodyn Ther; 2018 Mar; 21():263-274. PubMed ID: 29307774
[TBL] [Abstract][Full Text] [Related]
20. A metabolomic perspective of griseofulvin-induced liver injury in mice.
Liu K; Yan J; Sachar M; Zhang X; Guan M; Xie W; Ma X
Biochem Pharmacol; 2015 Dec; 98(3):493-501. PubMed ID: 26343413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
